Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Biotech IPOs: Outliers, Value Creation And The Dispersion Of Returns
Biotech IPOs: Outliers, Value Creation And The Dispersion Of Returns
Biotech IPOs: Outliers, Value Creation And The Dispersion Of Returns
Submitted by
admin
on September 27, 2016 - 10:15am
Source:
Forbes
News Tags:
biotech
IPOs
Headline:
Biotech IPOs: Outliers, Value Creation And The Dispersion Of Returns
Do Not Allow Advertisers to Use My Personal information
